There were, however, major design differences (other than treatment regimen) among these trials. One that may have had a critical bearing on the trial findings was that the primary outcomes of the 4D and AURORA trials included substantial numbers of events that were nonatherosclerotic (and hence could not have been prevented by lowering cholesterol), whereas the key outcome of the SHARP trial included only atherosclerotic events (11, 12) . Kingdom. E-mail: colin.baigent@ctsu.ox.ac.uk. 
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